Kolaideris - Company finances
|
EUR
|
2018
From: 2018-07-13
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,091 | 0 | 20,979 | 0 | 25,000 | 26,110 | 32,950 | 1,400 |
| Profit before tax | -59 | -18 | 15,382 | -42 | 23,093 | 15,378 | 4,141 | 13,432 |
| Net profit | -59 | -18 | 14,613 | -42 | 21,940 | 14,609 | 3,934 | 13,432 |
| Equity | 142 | 121 | 14,734 | 14,693 | 36,633 | 51,242 | 55,176 | 68,608 |
| Liabilities | - | - | - | - | 59,941 | 52,534 | 60,927 | 51,603 |
| Non-current assets | 0 | 0 | 0 | 0 | 96,350 | 96,350 | 0 | 0 |
| Current assets | 993 | 621 | 16,003 | 15,193 | 224 | 7,426 | 116,103 | 120,211 |
| Total assets | 993 | 621 | 16,003 | 15,193 | 96,574 | 103,776 | 116,103 | 120,211 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,417 | 1,469 | 1,054 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | +4.4% | +26.2% | -95.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -5.9% | -2.9% | 91.3% | -0.3% | 22.7% | 14.1% | 3.4% | 11.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -41.5% | -14.9% | 99.2% | -0.3% | 59.9% | 28.5% | 7.1% | 19.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.2% | - | 69.7% | - | 87.8% | 56.0% | 11.9% | 959.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.2% | - | 73.3% | - | 92.4% | 58.9% | 12.6% | 959.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 1.6 | 1.0 | 1.1 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | 1,400 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kolaideris - Social security debts
The company had no debts to Sodra
Kolaideris - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Kolaideris is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2026-09-02 | 0.32 |
| 2024-11-20 | 2025-06-11 | 0.32 |
| 2024-11-18 | 2024-11-19 | 301.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kolaideris, MB (code 304875205) is a Small partnership engaged in research and development in medical sciences. In 2025, the company generated EUR 1.4K in revenue and EUR 13.4K in net profit. The sharp fall in turnover compared with 2024, when revenue reached EUR 33.0K, means the latest profit margin is not representative of underlying operating scale. Over the three-year period, revenue rose from EUR 26.1K in 2023 to EUR 33.0K in 2024, before declining sharply in 2025, while net profit moved from EUR 14.6K to EUR 3.9K and then recovered to EUR 13.4K. At year-end 2025, total assets stood at EUR 120.2K, with equity of EUR 68.6K and liabilities of EUR 51.6K. The equity ratio was 57.1% and debt to equity 0.75, indicating a balanced capital structure. ROE was 19.6% and ROA 11.2%. Asset turnover remained low at 0.01x. Revenue per employee was EUR 1.4K, reflecting the very limited sales base in 2025.